NO20074102L - Rensing av Rapamycin - Google Patents

Rensing av Rapamycin

Info

Publication number
NO20074102L
NO20074102L NO20074102A NO20074102A NO20074102L NO 20074102 L NO20074102 L NO 20074102L NO 20074102 A NO20074102 A NO 20074102A NO 20074102 A NO20074102 A NO 20074102A NO 20074102 L NO20074102 L NO 20074102L
Authority
NO
Norway
Prior art keywords
rapamycin
purification
purified rapamycin
chemical process
obtaining
Prior art date
Application number
NO20074102A
Other languages
English (en)
Norwegian (no)
Inventor
Bogdan Kazimierz Wilk
Warren Chew
Chia-Cheng Shaw
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20074102L publication Critical patent/NO20074102L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20074102A 2005-03-02 2007-08-08 Rensing av Rapamycin NO20074102L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65791005P 2005-03-02 2005-03-02
PCT/US2006/006212 WO2006093745A1 (en) 2005-03-02 2006-02-22 Purification of rapamycin

Publications (1)

Publication Number Publication Date
NO20074102L true NO20074102L (no) 2007-09-26

Family

ID=36568679

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074102A NO20074102L (no) 2005-03-02 2007-08-08 Rensing av Rapamycin

Country Status (15)

Country Link
US (1) US7384953B2 (zh)
EP (1) EP1853612A1 (zh)
JP (1) JP2008531686A (zh)
KR (1) KR20070107087A (zh)
CN (1) CN101133065A (zh)
AU (1) AU2006218918A1 (zh)
CA (1) CA2599582A1 (zh)
CR (1) CR9297A (zh)
IL (1) IL185077A0 (zh)
MX (1) MX2007010716A (zh)
NI (1) NI200700225A (zh)
NO (1) NO20074102L (zh)
RU (1) RU2007130406A (zh)
WO (1) WO2006093745A1 (zh)
ZA (1) ZA200707523B (zh)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100402031C (zh) 2002-07-30 2008-07-16 惠氏公司 含有瑞帕霉素羟基酯的胃肠外制剂
KR20090080110A (ko) * 2006-11-10 2009-07-23 바이오콘 리미티드 순수형태의 라파마이신 그리고 그의 회수 및 정제 방법
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US20080175887A1 (en) 2006-11-20 2008-07-24 Lixiao Wang Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
JP2012533548A (ja) 2009-07-14 2012-12-27 バイオジェン・アイデック・エムエイ・インコーポレイテッド 組成物における黄色形成および過酸化物形成を阻害する方法
CN102443012B (zh) * 2010-10-13 2016-03-02 鲁南制药集团股份有限公司 一种从发酵液中提纯雷帕霉素的方法
CN103705925B (zh) 2012-09-29 2018-03-30 段磊 抑制PI3K/AKT/mTOR信号通路的药物组合
US9750728B2 (en) 2012-09-29 2017-09-05 Targeted Therapeutics, Llc Method and pharmaceutical composition for inhibiting PI3K/AKT/mTOR signaling pathway
ES2897473T3 (es) 2013-03-15 2022-03-01 Biosensors Int Group Ltd Purificación de derivados de la rapamicina
JP6529012B2 (ja) 2013-10-08 2019-06-12 エイアイ・セラピューティクス・インコーポレーテッド リンパ脈管筋腫症の処置のためのラパマイシン
CA2944075C (en) 2014-04-04 2022-06-28 Lam Therapeutics, Inc. An inhalable rapamycin formulation for treating age-related conditions
RU2732908C2 (ru) 2014-10-07 2020-09-24 ЭйАй ТЕРАПЬЮТИКС, ИНК. Ингаляционная лекарственная форма рапамицина для лечения легочной гипертензии
WO2016130645A1 (en) 2015-02-10 2016-08-18 Lam Therapeutics, Inc. Rapamycin for the treatment of lymphangioleiomyomatosis
BR112019002689A2 (pt) 2016-08-10 2019-05-14 Univ Texas terapia com rapamicina tópica
CN109369679A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种雷帕霉素的精制方法
CN109369680A (zh) * 2018-12-24 2019-02-22 江苏卓和药业有限公司 一种依维莫司的纯化方法
CN109485657A (zh) * 2018-12-24 2019-03-19 江苏卓和药业有限公司 一种替西罗莫司的纯化方法
EP3927319A1 (en) 2019-02-20 2021-12-29 AI Therapeutics, Inc. Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US6277983B1 (en) 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
BRPI0412659A (pt) 2003-07-16 2006-09-26 Wyeth Corp isÈmero c de cci-779, seu processo de preparação, composição farmacêutica compreendendo o mesmo e pacote farmacêutico contendo o referido composto
WO2005016935A2 (en) 2003-08-07 2005-02-24 Wyeth Regioselective synthesis of cci-779

Also Published As

Publication number Publication date
WO2006093745A1 (en) 2006-09-08
JP2008531686A (ja) 2008-08-14
US7384953B2 (en) 2008-06-10
NI200700225A (es) 2008-07-03
KR20070107087A (ko) 2007-11-06
AU2006218918A1 (en) 2006-09-08
RU2007130406A (ru) 2009-04-10
US20060199954A1 (en) 2006-09-07
CR9297A (es) 2008-01-21
CA2599582A1 (en) 2006-09-08
CN101133065A (zh) 2008-02-27
IL185077A0 (en) 2007-12-03
ZA200707523B (en) 2010-02-24
MX2007010716A (es) 2008-01-16
EP1853612A1 (en) 2007-11-14

Similar Documents

Publication Publication Date Title
NO20074102L (no) Rensing av Rapamycin
CY1121372T1 (el) Μεθοδος για την παρασκευη καθαρισμενων ανσαμιτοκινων
NO20056149L (no) Fremgangsmate og reaktor for produksjon av karbon nanoror
DK2292607T3 (da) Fremgangsmåde til syntese af organiske forbindelser
DK2781593T3 (da) Fremgangsmåde til behandling af methanemissioner
DK2057136T3 (da) Fremgangsmåde til syntese og/eller oprensning af diaminophenothiazinium forbindelser
DK1654438T3 (da) Fremgangsmåde til naturgasproduktion
NO20071464L (no) Fremgangsmate og reaktor for produksjon av hydrogen
DK3336073T3 (da) Fremgangsmåde til fremstilling af fluorerede organiske forbindelser
NO20081269L (no) Utvidbare metadata
DK1542928T3 (da) Airliftmembranindretning og membranbioreaktor og bioreaktorfremgangsmåde dermed
NO20070608L (no) Anvendelse av 2-tio-3,5-dicyano-4-fenyl-6-aminopyridiner ved behandling av kvalme og oppkast
MA29870B1 (fr) Nouveaux dérivés de 1-azabicycloalkyles dans le traitement de troubles psychotiques et neurodégénératifs
GB0600764D0 (en) Organic compound, optical crystal film and method of production thereof
GB0520489D0 (en) Organic compound, optical crystal film and method of producing thereof
MX2008007808A (es) Analogos de rifamicina y usos de ellos.
FR2907689B1 (fr) Procede de traitement du methane imbrule par oxydation par plasma
NO20071254L (no) Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
NO20080131L (no) Fremgangsmate for rensing av IL-18 bindende protein
NO20054903D0 (no) Fremgangsmate for rensing av koksverk-avlopsvann med gasspermeabel membran
NO20055188D0 (no) Armeringssystem og fremgangsmate for anvendelse og produksjon av slikt system
NL1034604A1 (nl) Verwijdering van waterstofcyanide uit synthesegas.
GT200500350A (es) Proceso de manufactura de compuestos organicos
FI20050145A0 (fi) Menetelmä biomassan käsittelemiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application